Inactive Instrument

News Echo Therapeutics Inc Nasdaq

Equities

US27876L2060

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Chief Executive Officer	17-03-22	CI
Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Interim Chief Executive Officer	16-11-23	CI
Echo Therapeutics, Inc. Announces Resignation of Dr. Elazer Edelman as Member of the Board of Directors and Audit Committee	16-09-27	CI
Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2016	16-08-12	CI
Echo Therapeutics, Inc.(OTCPK:ECTE) dropped from S&P TMI Index	16-07-13	CI
Echo Therapeutics, Inc. Primary Exchange Listing will Change to OTCQB Marketplace from Nasdaq Capital Market	16-07-12	CI
Echo Therapeutics, Inc.(NasdaqCM:ECTE) dropped from NASDAQ Composite Index	16-07-11	CI
Echo Therapeutics, Inc. Announces Institutional Review Board Approval of New Protocol	16-06-13	CI
Echo Therapeutics Seeks Acquisitions	16-06-10	CI
Echo Therapeutics, Inc. Announces New Appointments	16-05-26	CI
Echo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2016	16-05-20	CI
Echo Therapeutics, Inc. announced that it has received $4.47 million in funding.	16-05-02	CI
Echo Therapeutics, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2015	16-03-30	CI
Echo Therapeutics Issues Promissory Note to Platinum Partners Value Arbitrage Fund	16-03-22	CI
Echo Therapeutics, Inc. announced that it expects to receive $4.47 million in funding.	16-01-28	CI
Echo Therapeutics, Inc. Appoints Elazer Edelman to its Board of Directors	15-12-28	CI
Echo Therapeutics, Inc. Announces Earnings Results for the Third Quarter Ended September 30, 2015	15-11-16	CI
Echo Therapeutics, Inc. announced that it expects to receive $0.32 million in funding from Beijing Yi Tang Bio Science & Technology, Ltd., Platinum Management (NY) LLC, and another investor.	15-09-23	CI
Echo Therapeutics, Inc. announced that it expects to receive $0.15 million in funding from Platinum Management (NY) LLC and Beijing Yi Tang Bio Science & Technology, Ltd.	15-08-26	CI
Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2015	15-08-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Echo Therapeutics Inc Nasdaq

Equities

US27876L2060

Summary

Filters